CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-28 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +13,160 | 13,160 | ||
| 2025-12-19 | MORE ROBERT J Director | Sale 10b5-1 | −10,000 | $25.00 | $250K | 3,823,425 |
| 2025-11-21 | MORE ROBERT J Director | Sale 10b5-1 | −246,871 | $20.25 | $5.0M | 3,833,425 |
| 2025-05-29 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +22,200 | 22,200 | ||
| 2024-05-29 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +18,600 | 18,600 | ||
| 2023-05-31 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-06-13 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2021-09-17 | MORE ROBERT J Director | Conversion | +3,811,117 | 3,924,046 | ||
| 2021-09-17 | MORE ROBERT J Director | Purchase | +156,250 | $16.00 | $2.5M | 4,080,296 |
| 2021-09-17 | MORE ROBERT J Director | Conversion · Series A Preferred Stock | −1,212,122 | 0 | ||
| 2021-09-17 | MORE ROBERT J Director | Conversion · Series B Preferred Stock | −255,160 | 0 |
Page 1 of 1 · 11 trades